AR033914A1 - Compuestos triciclicos dihidroquinolina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen - Google Patents
Compuestos triciclicos dihidroquinolina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienenInfo
- Publication number
- AR033914A1 AR033914A1 ARP020101905A ARP020101905A AR033914A1 AR 033914 A1 AR033914 A1 AR 033914A1 AR P020101905 A ARP020101905 A AR P020101905A AR P020101905 A ARP020101905 A AR P020101905A AR 033914 A1 AR033914 A1 AR 033914A1
- Authority
- AR
- Argentina
- Prior art keywords
- optionally substituted
- group
- cycle
- hydrogen
- triciclic
- Prior art date
Links
- IRFSXVIRXMYULF-UHFFFAOYSA-N 1,2-dihydroquinoline Chemical class C1=CC=C2C=CCNC2=C1 IRFSXVIRXMYULF-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 3
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 229940041181 antineoplastic drug Drugs 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000002619 bicyclic group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 125000005415 substituted alkoxy group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Un compuesto de fórmula (1) en la cual la línea punteada representa un enlace simple o doble, el ciclo A representa un ciclo de anillo seleccionado entre fórmulas (2) a (6); R9a, R9b, R9c, X e Y son tal como se han definido en la descripción; R1 representa un grupo seleccionado entre hidrógeno, arilo, heteroarilo, ciclaolquilo, opcionalmente alquilo sustituido, y COR11 en la cual R11 es tal como se ha definido en la descripción, R2 a R8 representa cada uno un grupo seleccionado entre hidrógeno, hidroxi, polialquilo, nitro, alquilo opcionalmente sustituido, amino, opcionalmente sustituido, alcoxi opcionalmente sustituido, -OPO(OH)2 y un resto de fórmula (7). En la cual m representa un entero tal como 1 L m L 4, o R2 con R3 con R4, o R4 con R5, forman junto con los átomos de carbono que los contienen un grupo mono- o bicíclico, opcionalmente sustituido, que contiene opcionalmente 1 o 2 heteroátomos, R16 representa un átomo de hidrógeno o un grupo alquilo, el ciclo B representa un grupo arilo, heteroarilo o arilalquilo, sus isómeros ópticos, sales de adición de los mismos con un ácido farmacéuticamente aceptable y los hidratos y solvatos de los mismos. Medicamentos anticancerosos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0106791A FR2825092B1 (fr) | 2001-05-23 | 2001-05-23 | Nouveau derives trycicliques de dihydro-quinoleines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR033914A1 true AR033914A1 (es) | 2004-01-07 |
Family
ID=8863588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP020101905A AR033914A1 (es) | 2001-05-23 | 2002-05-23 | Compuestos triciclicos dihidroquinolina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20040180917A1 (es) |
| EP (1) | EP1399455A2 (es) |
| JP (1) | JP2004529191A (es) |
| KR (1) | KR20040008190A (es) |
| CN (1) | CN1511161A (es) |
| AR (1) | AR033914A1 (es) |
| BR (1) | BR0209963A (es) |
| CA (1) | CA2448197A1 (es) |
| CZ (1) | CZ20033496A3 (es) |
| EA (1) | EA200301172A1 (es) |
| FR (1) | FR2825092B1 (es) |
| HU (1) | HUP0401345A3 (es) |
| MX (1) | MXPA03010597A (es) |
| NO (1) | NO20035214L (es) |
| PL (1) | PL364083A1 (es) |
| SK (1) | SK16012003A3 (es) |
| WO (1) | WO2002094840A2 (es) |
| ZA (1) | ZA200308628B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2013014900A (es) | 2011-06-17 | 2014-02-17 | Merck Sharp & Dohme | Tetrahidroquinolinas condensadas con cicloalquilo como moduladores de la molecula receptora homologa quimioatrayente expresada en celulas t auxiliares de tipo 2. |
| JP2017503026A (ja) | 2014-01-15 | 2017-01-26 | サントル ナシオナル ドゥ ラ ルシェルシュ シアンティフィーク（セーエヌエールエス） | 水溶性４−アザポドフィルロトキシン類似体 |
| US11731980B1 (en) | 2023-03-22 | 2023-08-22 | King Faisal University | Furo[3,4-b]quinolone compounds as antibacterial agents |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2801310B1 (fr) * | 1999-11-24 | 2004-04-16 | Adir | NOUVEAUX DERIVES DE DIHYDROFURO-[3,4-b]QUINOLEIN-1-ONES, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT |
-
2001
- 2001-05-23 FR FR0106791A patent/FR2825092B1/fr not_active Expired - Fee Related
-
2002
- 2002-05-22 PL PL02364083A patent/PL364083A1/xx not_active Application Discontinuation
- 2002-05-22 CN CNA028103483A patent/CN1511161A/zh active Pending
- 2002-05-22 JP JP2002591513A patent/JP2004529191A/ja active Pending
- 2002-05-22 US US10/477,244 patent/US20040180917A1/en not_active Abandoned
- 2002-05-22 KR KR10-2003-7015307A patent/KR20040008190A/ko not_active Application Discontinuation
- 2002-05-22 WO PCT/FR2002/001716 patent/WO2002094840A2/fr not_active Application Discontinuation
- 2002-05-22 EP EP02735551A patent/EP1399455A2/fr not_active Withdrawn
- 2002-05-22 MX MXPA03010597A patent/MXPA03010597A/es unknown
- 2002-05-22 EA EA200301172A patent/EA200301172A1/ru unknown
- 2002-05-22 SK SK1601-2003A patent/SK16012003A3/sk unknown
- 2002-05-22 BR BR0209963-2A patent/BR0209963A/pt not_active IP Right Cessation
- 2002-05-22 CA CA002448197A patent/CA2448197A1/fr not_active Abandoned
- 2002-05-22 HU HU0401345A patent/HUP0401345A3/hu unknown
- 2002-05-22 CZ CZ20033496A patent/CZ20033496A3/cs unknown
- 2002-05-23 AR ARP020101905A patent/AR033914A1/es unknown
-
2003
- 2003-11-05 ZA ZA200308628A patent/ZA200308628B/en unknown
- 2003-11-24 NO NO20035214A patent/NO20035214L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| FR2825092A1 (fr) | 2002-11-29 |
| NO20035214D0 (no) | 2003-11-24 |
| EP1399455A2 (fr) | 2004-03-24 |
| KR20040008190A (ko) | 2004-01-28 |
| CA2448197A1 (fr) | 2002-11-28 |
| CZ20033496A3 (cs) | 2004-04-14 |
| WO2002094840A3 (fr) | 2003-05-01 |
| HUP0401345A2 (hu) | 2004-11-29 |
| CN1511161A (zh) | 2004-07-07 |
| FR2825092B1 (fr) | 2005-01-14 |
| ZA200308628B (en) | 2004-11-05 |
| NO20035214L (no) | 2003-11-24 |
| WO2002094840A2 (fr) | 2002-11-28 |
| HUP0401345A3 (en) | 2006-11-28 |
| SK16012003A3 (sk) | 2004-06-08 |
| PL364083A1 (en) | 2004-12-13 |
| EA200301172A1 (ru) | 2004-04-29 |
| MXPA03010597A (es) | 2004-03-09 |
| US20040180917A1 (en) | 2004-09-16 |
| JP2004529191A (ja) | 2004-09-24 |
| BR0209963A (pt) | 2004-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY29312A1 (es) | Piperazin-1-carboxamidas n,4,sustituidas y sus derivados, composiciones que los contienen, procedimientos de preparación y aplicaciones | |
| AR036106A1 (es) | Compuestos azaindoles inhibidores de quinasa selectivos, composiciones farmaceuticas y el uso de dicha composicion para la fabricacion de un medicamento | |
| AR069796A1 (es) | Derivados de bencimidazol, sustituido por carboxilo o por hidroxilo, proceso para prepararlos y composiciones farmaceuticas que los contienen | |
| AR081932A1 (es) | Derivados de heteroaril imidazolona, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades neoplasicas y autoinmunes | |
| CO5170521A1 (es) | Compuestos farmaceuticos de pirimidinona | |
| AR070992A1 (es) | Derivados de 2-aril-6-fenil-inidazo[1,2a]piridinas, su preparacion, composiciones farmaceuticas y su uso en enfermedades que implican los receptores nucleares nurr-1 | |
| CR7950A (es) | Sintesis de los cloruros de 4amino -2butenoilo y su uso en la preparacion of 3- cianoquinolinas | |
| ECSP034475A (es) | Derivados de 4-fenil-piridin como antagonistas del receptor de neuroquinina-1 | |
| CO5700768A2 (es) | Derivados de benzoxazina y sus usos | |
| AR034792A1 (es) | Derivados de 1-fenilsulfonil-1,3-dihidro-2h-indol-2-ona, su preparacion y su aplicacion en terapeutica | |
| HUP0401784A2 (hu) | Heterobiciklikus szerkezetû virális polimeráz inhibitorok, eljárás az elõállításukra, köztitermékek és ezeket tartalmazó gyógyszerkészítmények | |
| MY140528A (en) | Spiroketal derivatives and their use as therapeutic agents for diabetes | |
| HUP0300565A2 (hu) | PDE 5 inhibitor hatású 8-kinolin-xantin- és 8-izo-kinolin-xantin-származékok, alkalmazásuk, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| AR044629A1 (es) | Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos. | |
| ECSP045278A (es) | Compuestos de oxo-azabicíclicos | |
| AR039988A1 (es) | Derivados de benzoxazina como moduladores de 5-ht6 y usos de los mismos | |
| AR053835A1 (es) | Tetrahidropiridoazepin - 8 - onas como moduladores del receptor de dopamina d2 y compuestos relacionados para el tratamiento de la esquizofrenia y otros trastornos del snc, composiciones farmaceuticas que los contienen y su empleo en la preparacion de medicamentos. | |
| AR042155A1 (es) | Aminoalcoxiindoles, composicion farmaceutica que los comprenden y usos | |
| CO4940485A1 (es) | Nuevos derivados de triazole, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
| MXPA02012569A (es) | Ftalidas substituidas novedosas, un procedimiento para su preparacion y las composiciones farmaceuticas que contienen a las mismas. | |
| AR033914A1 (es) | Compuestos triciclicos dihidroquinolina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
| AR018632A1 (es) | Compuestos derivados de acido 1,2,3,4-tetrahidroquinolin-2-carboxilico, su uso en la fabricacion de medicamentos, composicion farmaceutica que los contiene, proceso para su preparacion. | |
| HUP0203187A2 (hu) | Izoxazolszármazékok mint foszfodiészteráz VII inhibitorok és ezeket tartalmazó gyógyszerkészítmények | |
| AR033915A1 (es) | Compuestos triciclicos dihidroquinolina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
| GB0617867D0 (en) | Chemical compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |